{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "FTK",
  "name": "Flotek Industries, Inc.",
  "url": "https://orbyd.app/dossiers/FTK/",
  "json_url": "https://orbyd.app/dossiers/FTK.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Legacy oilfield chemistry re-rating into a power/measurement business: Data Analytics hit 51% of gross profit in Q2 2026, the 2026-08-03 PREPA award adds ~$400M of 10-year expected backlog, and the 2026-08-04 guide went to $340–350M from $270–290M. Both catalysts have printed, RSI(14) is 71.5 and consensus PT $36.92 sits at spot.",
  "invalidation_trigger": "A weekly close below $28 un-prices the 2026-08-03 PREPA award and the 2026-08-04 guidance raise; secondary break is the Q4 2026 PREPA equipment-deployment window closing with no equipment in service, or a FY2026 revenue guide trim at the ~2026-11-03 Q3 print.",
  "catalyst_date": "2026-08-18",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "industrial-power-grid",
    "managed-care-health-services",
    "ai-datacenter-infrastructure",
    "oil-energy-geopolitical"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "FY2026 guidance of $340–350M revenue explicitly excludes PREPA contract revenue, which the company expects to begin in Q1 2027.",
    "Related-party revenue (ProFrac relationship) was $7.1M of the $19.2M Q2 2026 Data Analytics segment — it recurs in every quarterly segment disclosure.",
    "36.22M shares outstanding and beta 1.48: a small float that gaps on single headlines in both directions.",
    "PREPA is a government-owned utility with a long history of debt restructuring under federal oversight; backlog is expected revenue, not a receivable."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg being bought is a pivot away from oilfield chemistry into measurement, control and distributed power. In Q2 2026 (reported 2026-08-04) the Data Analytics segment produced 51% of total gross profit against Chemistry's 49% — the first quarter that mix inverted — on segment revenue of $19.2M, up 223% YoY. One day earlier, on 2026-08-03, Flotek disclosed a 10-year contract supporting a 400 MW gas-fired project for the Puerto Rico Electric Power Authority with approximately $400M of expected revenue backlog and roughly $40M of annual revenue at full deployment. The market re-rated the whole company on the second business: the shares closed $35.42 on 2026-08-07, 2.8% under the 52-week closing high of $36.43, after a 121.8% three-month advance, with RSI(14) at 71.5.\n\nBoth catalysts that produced the move have already printed. The question the next two quarters answer is whether PWRtek converts a single utility award into a repeatable contract stream, or whether 2026 is a chemistry-cycle year wearing a power-infrastructure label.\n\n## Bull Case\n\n- **Q2 2026 (2026-08-04): EPS $0.26 vs $0.12 consensus; revenue $99.367M vs $67.720M consensus.** A 47% revenue beat is not a rounding difference in estimates — it is a business the sell-side was not modelling.\n- **FY2026 guidance raised to $340–350M revenue and $47–51M adjusted EBITDA, from $270–290M and $36–41M** (2026-08-04). Prior consensus stood at $285.25M. The raised range explicitly **excludes** PREPA revenue, which the company expects to begin in Q1 2027.\n- **PREPA award (2026-08-03):** up to 40 MW of PWRtek primary generation capacity plus up to six pairs of smart conditioning/distribution skids inside a 400 MW project, delivered with partner Power Expectations LLC. Support equipment deployment is guided to Q4 2026; initial generation and skids by end of Q1 2027.\n- **Installed-base math is visible, not promised:** 89 XSPCT digital valuation units deployed or on order versus 25 active units at year-end 2025, against a company-identified addressable set of more than 200,000 US deployment locations (Q2 2026 materials).\n- **Chemistry is growing into a shrinking market.** US frac fleets averaged 182 in Q2 2026 versus 192 a year earlier, while domestic chemistry revenue rose 43% and international chemistry hit $10.6M, up 172% YoY — a single quarter that matched 94% of full-year 2025 international revenue.\n- **The balance sheet is not the constraint:** net debt $45.5M at 2026-06-30 with leverage at 0.9x, down from 1.1x at year-end 2025. Adjusted EBITDA of $16.8M in the quarter more than doubled from $8.0M.\n\n## Bear Case\n\n- **The re-rating has outrun the published targets.** Five analysts carry a consensus price target of $36.92 (Simply Wall St, 2026-08-07) against a $35.42 close; JonesTrading's $40, initiated 2026-07-09, is the high mark on the tape. Consensus 2026 revenue was lifted to $333M and EPS to $0.77, but the price has already absorbed that revision.\n- **Related-party revenue is structural.** Of the $19.2M Data Analytics quarter, $7.1M was related-party — the ProFrac relationship remains embedded in the segment now carrying the story.\n- **PREPA is a government counterparty with a long history of debt restructuring under federal oversight.** Contracted backlog is an expectation of revenue, not a receivable; nothing bills until equipment is in service, and the first tranche is guided to Q4 2026.\n- **Guidance excludes the thing the stock re-rated on.** FY2026 has to be carried entirely by chemistry and existing analytics work; PREPA cannot rescue a Q3 or Q4 shortfall.\n- **Capital intensity is rising with the unit count.** Going from 25 active analyzers to 89 deployed-or-on-order is a working-capital and capex event; the company's own Q2 deck put market cap at $846M on 2026-06-30 against $1.28B on 2026-08-07 — an equity window that did not exist six weeks ago.\n\n## Setup & Price Structure\n\nClose $35.42 on 2026-08-07, down 2.77% on the session, against a 52-week closing high of $36.43 and a 12-month low of $10.95. Three-month return 121.8%; RSI(14) 71.5, above the overbought threshold and rising into the print rather than after it. Beta 1.48 on 36.22M shares outstanding — a float small enough that single headlines move the whole capitalisation, which is what happened across 2026-08-03 and 2026-08-04.\n\nPositioning observables, stated as observables: the consensus price target sits essentially at spot, so the sell-side provides no headroom without further estimate revisions; retail-facing coverage clustered heavily in the 2026-08-03 to 2026-08-05 window (deal, beat, guidance raise, sympathy movers lists); the shares closed the most recent session lower despite no negative company news, the first distribution day since the catalysts. No Form 4 activity and no registration statement appear in the trailing 30-day filing feed for this name — an issuance into strength, if it comes, shows up there first.\n\nStructurally, price is consolidating within 3% of its high after a vertical move, with no base built at these levels. The mid-$20s is where this traded before 2026-08-03.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-17 to 2026-08-19** — EnerCom Denver energy investment conference. Coverage of the Q2 release listed Flotek among scheduled presenters; the specific slot is unconfirmed here. First venue for management commentary on the PREPA deployment schedule outside the print.\n- **~2026-11-03 (est.)** — Q3 2026 results. Outside the 30-day window, and the next hard test of the $340–350M FY guide.\n- **~2026-12-31 (est.)** — PREPA support equipment deployment, guided to Q4 2026. No fixed date disclosed.\n\nNothing else inside 30 days is hard-dated. That is the current condition of the name: the catalysts are behind it and the next binary is roughly three months out.\n\n## What Would Change Our Mind\n\nThe fastest break is schedule slip. PREPA support equipment is guided to Q4 2026 with initial generation and skids by end of Q1 2027; if the Q3 print in early November carries no deployment confirmation, or pushes first revenue past Q1 2027, the $400M backlog reverts to a press release and the multiple loses its justification. A second break is inside the segment mix: Data Analytics reaching 51% of gross profit is the whole re-rating, and a sequential decline in that line — particularly a fall in the $7.1M related-party component — would say the inflection was a single quarter.\n\nOn the tape, the gradeable condition is a **weekly close below $28**, which would mean the market has largely un-priced the 2026-08-03 award and the 2026-08-04 raise while the guidance itself is unchanged. A trim to the FY2026 revenue range at the Q3 print would confirm the fundamental version of the same break.\n\n## Correlation Notes\n\n- **Pressure pumping / frac activity** remains the chemistry demand driver, and it is contracting: 182 average US frac fleets in Q2 2026 versus 192 a year earlier. Domestic chemistry grew 43% against that, so the correlation to fleet count has loosened but not broken.\n- **ProFrac** is the related party behind $7.1M of Q2 Data Analytics revenue; its activity levels and capex flow through both segments.\n- **Distributed gas power and grid-resilience names** are the new comp set. The PREPA award and the company's stated ambition to support roughly 5 GW through measurement or control by Q1 2027 place FTK in the same flow as behind-the-meter and grid-enhancement equipment, which trades on power-demand headlines rather than on oil.\n- **Small-cap high-beta momentum:** 36.22M shares and beta 1.48 mean the name amplifies risk-on and risk-off in the Russell complex independently of anything in its own income statement.",
  "first_seen": "2026-08-07",
  "last_analyzed": "2026-08-08T07:53:33+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}